ImmunoACT
Rahul Purwar is an experienced Immunologist and Chief Executive Officer and Founder of ImmunoACT. With a background as an Associate Professor at the Indian Institute of Technology, Bombay, and previously as a Scientist II at ImmunoGen, Inc., Rahul focuses on developing affordable CART cell therapy. Rahul holds a Postdoctoral fellowship in Immunology from Harvard Medical School, a PhD in Molecular Medicine from Medizinische Hochschule Hannover, and degrees in Biochemistry and Chemistry.
ImmunoACT
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell & Gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.